Skip to main content
. 2020 Jul 24;8:655. doi: 10.3389/fcell.2020.00655

FIGURE 1.

FIGURE 1

Metabolic reprogramming activates epithelial–mesenchymal transition (EMT)-inducing transcription factor and induces the EMT process to promote breast cancer metastasis and drug resistance. Glucose-6P, glucose 6-phosphate; fructose-6P, fructose 6-phosphate; fructose-1-6P, fructose-1-6-phosphate; PGI, phosphoglucose isomerase; FBP1, fructose-1,6-bisphosphatase 1; PKM2, pyruvate kinase M2; PDH, pyruvate dehydrogenase; PDK1, pyruvate dehydrogenase kinase 1; TCA cycle, tricarboxylic acid cycle; mt DNA, mitochondrial DNA; FAO, fatty acid oxidation; Gln, glutamine; GLS2, glutaminase 2; DG, diglyceride; TG, triglyceride; LA, linoleic acid; AA, arachidonic acid; PGH2, prostaglandin H2; PGF2α, prostaglandin F2α; LDs, lipid droplets; ACC, acetyl-coA carboxylase; FASN, fatty acid synthase; AKR1B1, aldo-keto reductase 1 member B1; Glu, glutamate; Asp, aspartate; Asn, asparagine; ASNS, asparagine synthetase; ROS, reactive oxidative stress; EMT-TF, epithelial–mesenchymal transition transcription factor.